Brief: Cytodyn Submits Cmc (Manufacturing) Section Of Hiv BLA To FDA Under Previously Authorized Rolling Review Last (Clinical) Section Will Complete Full BLA Submission
01/12/2021 13:26
Dec 1 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN SUBMITS CMC (MANUFACTURING) SECTION OF HIV BLA TO
FDA
UNDER PREVIOUSLY AUTHORIZED ROLLING REVIEW; LAST (CLINICAL)
SECTION WILL COMPLETE FULL BLA SUBMISSION
Source text for Eikon: ID:nBw4z52Yda
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer